Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health (NYSE: CVS) has reopened its Hendersonville store at 522 South Main Street, which was severely damaged by Hurricane Helene in September. The store is the first to reopen at the intersection of South Main Street and Spartanburg Highway following extensive flood damage from Clear Creek.
The rebuilt store features an expanded pharmacy, private consultation and vaccination area, improved in-store delivery pickup area, and updated layout. CVS Health has provided over $1.5 million in support through grants and in-kind product donations to communities impacted by the hurricane.
The store operates Monday-Saturday 9:00 AM - 8:00 PM and Sunday 10:00 AM - 7:00 PM, with pharmacy hours varying by day.
The company generated $4.6 billion in operating cash flow and announced plans to exit the individual exchange business. Performance improved across all segments, with Health Care Benefits showing significant growth due to favorable prior-year development and improved Medicare performance.
CVS updated its 2025 guidance, revising GAAP EPS to $4.23-$4.43 (down from $4.58-$4.83) but raising Adjusted EPS to $6.00-$6.20 (up from $5.75-$6.00). Cash flow guidance was increased to approximately $7.0 billion. Notable developments include Aetna's new solutions for patient care and CVS Caremark's formulary update to improve access to GLP-1 drugs, particularly Wegovy through a partnership with Novo Nordisk.
CVS Health (NYSE: CVS) has announced key leadership changes, with Brian Newman appointed as executive vice president and CFO designate effective April 21, succeeding Tom Cowhey who will transition to a strategic advisor role. Additionally, Dr. Amy Compton-Phillips joins as executive vice president and chief medical officer effective May 19.
Based on year-to-date results through February, CVS expects to meet or exceed its previously issued guidance for full year 2025. Newman brings experience from UPS where he served as CFO, and previously spent 26 years at PepsiCo in various finance leadership roles. Dr. Compton-Phillips joins from Press Ganey and has extensive experience in healthcare operations and improvement programs, including roles at Providence Health & Services and Kaiser Permanente.
CVS Health (NYSE: CVS) has announced it will host its first quarter 2025 earnings conference call on Thursday, May 1st, 2025, at 8:00 a.m. ET. The event will include discussions of Q1 2025 financial results with analysts and investors. An audio webcast will be available simultaneously on the company's Investor Relations website at investors.cvshealth.com, where it will remain accessible for one year.
CVS Health (NYSE: CVS) has announced its board of directors' approval of a quarterly dividend of $0.665 per share on the company's Common Stock. The dividend will be distributed to shareholders of record as of April 22, 2025, with the payment scheduled for May 1, 2025.
CVS Health (NYSE: CVS) has released data from its CVS Weight Management™ program, showing participants achieved over 15% average weight loss. The program, now available to 3.5 million CVS Caremark plan members, combines one-on-one support from registered dietitians with personalized nutrition planning in a virtual setting.
Key findings reveal that CVS Caremark clients adopting the program spent up to 26% less on GLP-1 medications compared to non-adopting clients. The program demonstrated remarkable results: members who previously lost less than 1% body weight on anti-obesity medication achieved an average 11.7% weight loss after enrollment - a 13x increase. Additionally, those with moderate pre-program success reached an average 20% weight loss.
The program maintains a 92% satisfaction rate after six months, and notably, members who discontinued anti-obesity medication while maintaining lifestyle support retained 94% of their weight loss. These results are based on data from 265,000 members during 2023-2024.
CVS Health Foundation has announced a $2 million Health Zones funding to support the Hispanic Health Council's Family Wellness Center and its partners in Hartford, Connecticut. The initiative aims to address healthcare barriers for individuals with chronic health conditions, serving a state where over 2 million residents live with such conditions.
The funding will enable the Hispanic Health Council to hire three new patient navigators and provide comprehensive services including preventative care, nutrition counseling, mental health support, and community health education. Partner organizations include Mental Health Connecticut and the Villages for Families and Children.
Additionally, CVS Health offered free health screenings through its Project Health initiative, which screened over 450 participants resulting in 1,500+ screenings in Hartford last year. The program will be available in Hartford from June 3 to June 28.